Roxadustat

Status:
Red
Decision Date:
August 2022
 

Comments

NICE TA807 - Roxadustat for treating symptomatic anaemia in chronic kidney disease

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app